Department of Error (DOI:10.1016/S0140-6736(09)61754-2);Snake bite

The Lancet

Volumn 375, Issue 9708, 2010, Pages 77-88

  Warrell, David A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SNAKE VENOM; VENOM ANTISERUM;

ANAPHYLAXIS; BLOOD CLOTTING; DISEASE CLASSIFICATION; DRUG SAFETY; ENVENOMATION; EVOLUTION; FIRST AID; HEALTH EDUCATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PRURITUS; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; SNAKE; SNAKEBITE; TAXONOMY; URTICARIA;

EID: 73049107213     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60273-5     Document Type: Erratum

References (122)

1. Lucanus M.A. Bellum civile (civil war). Book IX. http://www.thelatinlibrary.com/lucan/lucan9.shtml (accessed Nov 23, 2009).
2. Öhman A. Has evolution primed humans to "beware the beast"?. Proc Natl Acad Sci USA 104 (2007) 16396-16397
3. Isbell L.A. Snakes as agents of evolutionary change in primate brains. J Hum Evol 51 (2006) 1-35
4. Williams D., Gutiérrez J.M., Harrison R., et al. The Global Snake Bite Initiative: an antidote for snake bite. Lancet 375 (2010) 89-91
5. Klauber L.M. Rattlesnakes. Their habits, life histories, and influence on mankind (1972), University of California Press, Berkeley 2e
6. Sclater W.L. List of snakes in the Indian Museum (1891), Trustees of the Indian Museum, Calcutta
7. Heatwole H. Sea snakes (1999), Krieger, Malabar 2e
8. Kuch U., Müller J., Mödden C., and Mebs D. Snake fangs from the Lower Miocene of Germany: evolutionary stability of perfect weapons. Naturwissenschaften 93 (2006) 84-87
9. Fry B.G. From genome to "venome": molecular origin and evolution of the snake venom proteome inferred from phylogenetic analysis of toxin sequences and related body proteins. Genome Res 15 (2005) 403-420
10. Fry B.G., Vidal N., van der Weerd L., Kochva E., and Renjifo C. Evolution and diversification of the Toxicofera reptile venom system. J Proteomics 72 (2009) 127-136
11. Vidal N., and Hedges S.B. Higher-level relationships of caenophidian snakes inferred from four nuclear and mitochondrial genes. C R Biol 325 (2002) 987-995
12. Wüster W., Peppin L., Pook C.E., and Walker D.E. A nesting of vipers: phylogeny and historical biogeography of the Viperidae (Squamata: Serpentes). Mol Phylogenet Evol 49 (2008) 445-459
13. Wüster W., Crookes S., Ineich I., et al. The phylogeny of cobras inferred from mitochondrial DNA sequences: evolution of venom spitting and the phylogeography of the African spitting cobras (Serpentes: Elapidae: Naja nigricollis complex). Mol Phylogenet Evol 45 (2007) 437-453
14. Pook C.E., Joger U., Stümpel N., and Wüster W. When continents collide: Phylogeny, historical biogeography and systematics of the medically important viper genus Echis (Squamata: Serpentes: Viperidae). Mol Phylogenet Evol (2009) 10.1016/j.ympev.2009.08.002 published online Aug 8.
15. Wüster W., and Thorpe R.S. Population affinities of the Asiatic cobra (Naja naja) species complex in south-east Asia: reliability and random resampling. Biol J Linn Soc Lond 36 (1989) 391-409
16. Wüster W., Otsuka S., Malhotra A., and Thorpe R.S. Population systematics of Russell's viper: a multivariate study. Biolog J Linnean Soc 47 (1992) 97-113
17. Malhotra A., and Thorpe R.S. A phylogeny of four mitochondrial gene regions suggests a revised taxonomy for Asian pitvipers (Trimeresurus and Ovophis). Mol Phylogenet Evol 32 (2004) 83-100
18. WHO. Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins (2010), World Health Organization, Geneva
19. Warrell D.A., Hudson B.J., Lalloo D.G., et al. The emerging syndrome of envenoming by the New Guinea small-eyed snake Micropechis ikaheka. Q J Med 89 (1996) 523-530
20. Wüster W., Warrell D.A., Cox M.J., Jintakune P., and Nabhitabhata J. Redescription of Naja siamensis, Laurenti, 1768 (Serpentes: Elapidae), a widely overlooked spitting cobra from Southeast Asia: geographic variation, medical importance and designation of a neotype. J Zool London 243 (1997) 771-788
21. Joseph J.K., Simpson I.D., Menon N.C., et al. First authenticated cases of life-threatening envenoming by the hump-nosed pit viper (Hypnale hypnale) in India. Trans R Soc Trop Med Hyg 101 (2007) 85-90
22. Warrell D.A. Proatheris superciliaris: the deadly venom of a rare and elusive snake revealed. Toxicon 52 (2008) 833-835
23. Campbell J.A., and Brodie E.D. Biology of the pitvipers (1992), Selva, Tyler
24. Harvey A.L. Snake toxins (1991), Pergamon, New York
25. Ménez A. The subtle beast. Snakes, from myth to medicine (2003), Taylor and Francis, London
26. Daltry J.C., Wüster W., and Thorpe R.S. Diet and snake venom evolution. Nature 379 (1996) 537-540
27. Barlow A., Pook C.E., Harrison R.A., and Wüster W. Coevolution of diet and prey-specific venom activity supports the role of selection in snake venom evolution. Proc Biol Sci 276 (2009) 2443-2449
28. Hilton-Jones D, Palace J. Disorders of the neuromuscular junction. In: Warrell DA, Cox TM, Firth JD, eds. Oxford textbook of medicine, 5th edn. Oxford: Oxford University Press (in press).
29. Gubensek F., Ritonja A., Cotic V., et al. Distribution of vipera ammodytes toxic phospholipase A in the cat and its ability to cross the blood-brain barrier. Toxicon 20 (1982) 191-194
30. Bevan P., and Hiestand P. Beta-RTX. A receptor-active protein from Russell's viper (Vipera russelli russelli) venom. J Biol Chem 258 (1983) 5319-5326
31. Saha A., Gomes A., Chakravarty A.K., et al. CNS and anticonvulsant activity of a non-protein toxin (KC-MMTx) isolated from king cobra (Ophiophagus hannah) venom. Toxicon 47 (2006) 296-303
32. Campbell C.H. The death adder (Acanthophis antarcticus): the effect of the bite and its treatment. Med J Aust 2 (1966) 922-925
33. Ménez A., Boulain J.C., Bouet F., et al. On the molecular mechanisms of neutralization of a cobra neurotoxin by specific antibodies. J Physiol (Paris) 79 (1984) 196-206
34. Gatineau E., Lee C.Y., Fromageot P., and Ménez A. Reversal of snake neurotoxin binding to mammalian acetylcholine receptor by specific antiserum. Eur J Biochem 171 (1988) 535-539
35. Warrell D.A., Greenwood B.M., Davidson N.M., et al. Necrosis, haemorrhage and complement depletion following bites by the spitting cobra (Naja nigricollis). Q J Med 45 (1976) 1-22
36. Watt G., Theakston R.D., Hayes C.G., et al. Positive response to edrophonium in patients with neurotoxic envenoming by cobras (Naja naja philippinensis). A placebo-controlled study. N Engl J Med 315 (1986) 1444-1448
37. Warrell D.A., Looareesuwan S., White N.J., et al. Severe neurotoxic envenoming by the Malayan krait Bungarus candidus (Linnaeus): response to antivenom and anticholinesterase. BMJ (Clin Res Ed) 286 (1983) 678-680
38. Kaminski H.J., Maas E., Spiegel P., and Ruff R.L. Why are eye muscles frequently involved in myasthenia gravis?. Neurology 40 (1990) 1663-1669
39. Ruff R.L. More than meets the eye: extraocular muscle is very distinct from extremity skeletal muscle. Muscle Nerve 25 (2002) 311-313
40. Hughes B.W., Kusner L.L., and Kaminski H.J. Molecular architecture of the neuromuscular junction. Muscle Nerve 33 (2006) 445-461
41. Rocha e Silva M., Beraldo W.T., and Rosenfeld G. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. Am J Physiol 156 (1949) 261-273
42. Ducancel F. Endothelin-like peptides. Cell Mol Life Sci 62 (2005) 2828-2839
43. Lisy O., Huntley B.K., McCormick D.J., Kurlansky P.A., and Burnett Jr. J.C. Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP. J Am Coll Cardiol 52 (2008) 60-68
44. Lu Q., Clemetson J.M., and Clemetson K.J. Snake venoms and hemostasis. J Thromb Haemost 3 (2005) 1791-1799
45. Gutiérrez J.M., Rucavado A., Chaves F., Díaz C., and Escalante T. Experimental pathology of local tissue damage induced by Bothrops asper snake venom. Toxicon 54 (2009) 958-975
46. WHO. Snakebite. http://www.who.int/neglected_diseases/diseases/snakebites/en/index.html (accessed Nov 23, 2009).
47. Swaroop S., and Grab B. Snakebite mortality in the world. Bull World Health Organ 10 (1954) 35-76
48. Chippaux J.P. Snake-bites: appraisal of the global situation. Bull World Health Organ 76 (1998) 515-524
49. Kasturiratne A., Wickremasinghe A.R., de Silva N., et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med 5 (2008) e218
50. bdnews24. Govt to train locals as survey reveals 6,000 snakebite deaths a year. http://www.bdnews24.com/details.php?id=139775&cid=2 (accessed Nov 23, 2009).
51. Jha P., Gajalakshmi V., Gupta P.C., et al., RGI-CGHR Prospective Study Collaborators. Prospective study of one million deaths in India: rationale, design, and validation results. PLoS Med 3 (2006) e18
52. Anon. Indian sanitary report. BMJ (1927) 538-539
53. Warrell D.A. WHO/SEARO Guidelines for the clinical management of snake bites in the Southeast Asian region. SE J Trop Med Publ Hlth 30 suppl 1 (1999) 1-85. http://www.searo.who.int/en/Section10/Section17/Section53/Section1024.ht m (accessed Nov 23, 2009).
54. Warrell D.A., and Arnett C. The importance of bites by the saw-scaled or carpet viper (Echis carinatus): epidemiological studies in Nigeria and a review of the world literature. Acta Trop 33 (1976) 307-341
55. Pugh R.N., Theakston R.D., and Reid H.A. Malumfashi Endemic Diseases Research Project, XIII. Epidemiology of human encounters with the spitting cobra, Naja nigricollis, in the Malumfashi area of northern Nigeria. Ann Trop Med Parasitol 74 (1980) 523-530
56. Trape J.F., Pison G., Guyavarch E., and Mane Y. High mortality from snakebite in south-eastern Senegal. Trans R Soc Trop Med Hyg 95 (2001) 420-423
57. Snow R.W., Bronzan R., Roques T., et al. The prevalence and morbidity of snake bite and treatment-seeking behaviour among a rural Kenyan population. Ann Trop Med Parasitol 88 (1994) 665-671
58. Hati A.K., Mandal M., De M.K., et al. Epidemiology of snake bite in the district of Burdwan, West Bengal. J Indian Med Assoc 90 (1992) 145-147
59. Sharma S.K., Chappuis F., Jha N., Bovier P.A., Loutan L., and Koirala S. Impact of snake bites and determinants of fatal outcomes in southeastern Nepal. Am J Trop Med Hyg 71 (2004) 234-238
60. WHO. International statistical classification of diseases and related health problems 10th revision version for 2007. http://apps.who.int/classifications/apps/icd/icd10online/ (accessed Nov 23, 2009).
61. Muelling R.J., Samson R.F., and Beven T. The precipitin test in elucidating the cause of death. Am J Clin Pathol 28 (1957) 489-494
62. Brunda G., and Sashidhar R.B. Epidemiological profile of snake-bite cases from Andhra Pradesh using immunoanalytical approach. Indian J Med Res 125 (2007) 661-668
63. Tun-Pe, Phillips R.E., Warrell D.A., et al. Acute and chronic pituitary failure resembling Sheehan's syndrome following bites by Russell's viper in Burma. Lancet 2 (1987) 763-767
64. Fayrer J. Destruction of life in India by poisonous snakes. Nature 27 (1882) 205-208
65. Grantham S.G., McDowell R.G., and Swithinbank B.W. Tharrawaddy district. Burma Gazetteer (Rangoon) (1959)
66. Ariaratnam C.A., Sheriff M.H., Theakston R.D., and Warrell D.A. Distinctive epidemiologic and clinical features of common krait (Bungarus caeruleus) bites in Sri Lanka. Am J Trop Med Hyg 79 (2008) 458-462
67. Chappuis F., Sharma S.K., Jha N., Loutan L., and Bovier P.A. Protection against snake bites by sleeping under a bed net in southeastern Nepal. Am J Trop Med Hyg 77 (2007) 197-199
68. Tun-Pe, Aye-Aye-Myint, Khin-Aye-Kyu, and Maung-Maung-Toe. Acceptability study of protective boots among farmers of Taungdwingyi township. Management of snakebite and research (2002), World Health Organization, New Delhi 7-11
69. Phillips R.E., Theakston R.D., Warrell D.A., et al. Paralysis, rhabdomyolysis and haemolysis caused by bites of Russell's viper (Vipera russelli pulchella) in Sri Lanka: failure of Indian (Haffkine) antivenom. Q J Med 68 (1988) 691-715
70. Warrell D.A. Clinical toxicology of snakebite in Africa and the Middle East/Arabian Peninsula. In: Meier J., and White J. (Eds). Handbook of clinical toxicology of animal venoms and poisons (1995), CRC Press, Boca Raton 433-492
71. Warrell D.A. Epidemiology, clinical features and management of snake bites in Central and South America. In: Campbell J., and Lama W.W. (Eds). Venomous reptiles of the western hemisphere (2004), Cornell University Press, Ithaca 709-761
72. Warrell D.A. Australian toxinology in a global context. Toxicon 48 (2006) 718-725
73. Anker R.L., Straffon W.G., Loiselle D.S., and Anker K.M. Retarding the uptake of "mock venom" in humans: comparison of three first-aid treatments. Med J Aust 1 (1982) 212-214
74. Tun-Pe, Aye-Aye-Myint, Khin-Ei-Han, et al. Local compression pads as a first-aid measure for victims of bites by Russell's viper (Daboia russelii siamensis) in Myanmar. Trans R Soc Trop Med Hyg 89 (1995) 293-295
75. Canale E., Isbister G.K., and Currie B.J. Investigating pressure bandaging for snakebite in a simulated setting: bandage type, training and the effect of transport. Emerg Med Australas 21 (2009) 184-190
76. Ariaratnam C.A., Sheriff M.H.R., Arambepola C., Theakston R.D.G., and Warrell D.A. Syndromic approach to treatment of snake bite in Sri Lanka based on results of a prospective national hospital-based survey of patients envenomed by identified snakes. Am J Trop Med Hyg 81 (2009) 725-731
77. Moffet M.W. Outside.online. Bit. http://outside.away.com/outside/adventure/200204/200204_bit_1.adp (accessed Nov 23, 2009).
78. Greenwood B.M., Warrell D.A., Davidson N.M., et al. Immunodiagnosis of snake bite. BMJ 4 (1974) 743-745
79. Coulter A.R., Sutherland S.K., and Broad A.J. Assay of snake venoms in tissue fluids. J Immunol Methods 4 (1974) 297-300
80. Theakston R.D.G., Lloyd-Jones M.J., and Reid H.A. Micro-ELISA for detecting and assaying snake venom and venom-antibody. Lancet 310 (1977) 639-641
81. O'Leary M.A., Isbister G.K., Schneider J.J., Brown S.G., and Currie B.J. Enzyme immunoassays in brown snake (Pseudonaja spp) envenoming: detecting venom, antivenom and venom-antivenom complexes. Toxicon 48 (2006) 4-11
82. Van Dong L., Quyen le K., Eng K.H., and Gopalakrishnakone P. Immunogenicity of venoms from four common snakes in the South of Vietnam and development of ELISA kit for venom detection. J Immunol Methods 282 (2003) 13-31
83. Chen T., Bjourson A.J., Orr D.F., et al. Unmasking venom gland transcriptomes in reptile venoms. Anal Biochem 311 (2002) 152-156
84. Ho M., Warrell M.J., Warrell D.A., et al. A critical reappraisal of the use of enzyme-linked immunosorbent assays in the study of snake bite. Toxicon 24 (1986) 211-221
85. Audebert F., Sorkine M., Robbe-Vincent A., and Bon C. Viper bites in France: clinical and biological evaluation; kinetics of envenomations. Hum Exp Toxicol 13 (1994) 683-688
86. Tanos P.P., Isbister G.K., Lalloo D.G., Kirkpatrick C.M., and Duffull S.B. A model for venom-induced consumptive coagulopathy in snake bite. Toxicon 52 (2008) 769-780
87. Isbister G.K., Duffull S.B., Brown S.G., and ASP Investigators. Failure of antivenom to improve recovery in Australian snakebite coagulopathy. Q J Med 102 (2009) 563-568
88. Isbister G.K., Halkidis L., O'Leary M.A., et al. Human anti-snake venom IgG antibodies in a previously bitten snake-handler, but no protection against local envenoming. Toxicon (2009) 10.1016/j.toxicon.2009.07.034 published online Aug 5.
89. Bon C. Serum therapy was discovered 100 years ago. In: Bon C., and Goyffon M. (Eds). Envenomings and their Treatments (1996), Fondation Marcel Mérieux, Lyon 3-9
90. Warrell D.A., Davidson N.M., Omerod L.D., et al. Bites by the saw-scaled or carpet viper (Echis carinatus): trial of two specific antivenoms. BMJ 4 (1974) 437-440
91. Sano-Martins I.S., Fan H.W., Castro S.C., et al. Reliability of the simple 20 minute whole blood clotting test (WBCT20) as an indicator of low plasma fibrinogen concentration in patients envenomed by Bothrops snakes. Toxicon 32 (1994) 1045-1050
92. Reid H.A., Thean P.C., Chan K.E., and Baharom A.R. Clinical effects of bites by Malayan viper (Ancistrodon rhodostoma). Lancet 281 (1963) 617-621
93. Reid H.A., Chan K.E., and Thean P.C. Prolonged coagulation defect (defibrination syndrome) in Malayan viper bite. Lancet 281 (1963) 621-626
94. Brown A.E., and Brown L. Blood venom antigen levels after Malayan pit viper bite. Trans R Soc Trop Med Hyg 81 (1987) 548
95. Warrell D.A., Looareesuwan S., Theakston R.D., et al. Randomized comparative trial of three monospecific antivenoms for bites by the Malayan pit viper (Calloselasma rhodostoma) in southern Thailand: clinical and laboratory correlations. Am J Trop Med Hyg 35 (1986) 1235-1247
96. Warrell D.A., Davidson N., Greenwood B.M., Ormerod L.D., Pope H.M., Watkins B.J., and Prentice C.R. Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria. Q J Med 46 (1977) 33-62
97. Abubakar SB, Abubakar IS, Nasidi A, et al. Randomized double blind comparative trial of two new antivenoms for the treatment of patients envenomed by the saw-scaled or carpet viper (Echis ocellatus) in northern Nigeria. Global Issues in Clinical Toxinology 2008 Conference; University of Melbourne, Australia; Nov 23-28, 2008.
98. Abubakar S.B., Abubakar I.S., Habib A.G., et al. Pre-clinical and preliminary dose-finding and safety studies to identify candidate antivenoms for treatment of envenoming by saw-scaled or carpet vipers (Echis ocellatus) in northern Nigeria. Toxicon (2009) 10.1016/j.toxicon.2009.10.024 published online Oct 27.
99. Myint-Lwin, Warrell D.A., Phillips R.E., et al. Bites by Russell's viper (Vipera russelli siamensis) in Burma: haemostatic, vascular, and renal disturbances and response to treatment. Lancet 326 (1985) 1259-1264
100. Ho M., Warrell D.A., Looareesuwan S., et al. Clinical significance of venom antigen levels in patients envenomed by the Malayan pit viper (Calloselasma rhodostoma). Am J Trop Med Hyg 35 (1986) 579-587
101. Hutton R.A., Looareesuwan S., Ho M., et al. Arboreal green pit vipers (genus Trimeresurus) of South-East Asia: bites by T albolabris and T macrops in Thailand and a review of the literature. Trans R Soc Trop Med Hyg 84 (1990) 866-874
102. Cardoso J.L., Fan H.W., Franca F.O., et al. Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in São Paulo, Brazil. Q J Med 86 (1993) 315-325
103. Pardal P.P., Souza S.M., Monteiro M.R., et al. Clinical trial of two antivenoms for the treatment of Bothrops and Lachesis bites in the north eastern Amazon region of Brazil. Trans R Soc Trop Med Hyg 98 (2004) 28-42
104. Smalligan R., Cole J., Brito N., et al. Crotaline snake bite in the Ecuadorian Amazon: randomised double blind comparative trial of three South American polyspecific antivenoms. BMJ 329 (2004) 1129
105. Rosenfeld G., Kelen E., and Nahas L. Regeneration of fibrinogen after defibrination by Bothropic venom in man and in dogs. Relationships with clotting and bleeding time. Colet Trab Inst Butantan 7 (1958-9) 36-44
106. Lalloo D.G., Trevett A.J., Owens D., et al. Coagulopathy following bites by the Papuan taipan (Oxyuranus scutellatus canni). Blood Coagul Fibrinolysis 6 (1995) 65-72
107. Bos M., Boltz M., St Pierre L., et al. Response to "Clinical relevance of brown snake (Pseudonaja spp) factor V escaping hemostatic regulation". Blood 114 (2009) 2563-2564
108. Meyer W.P., Habib A.G., Onayade A.A., et al. First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom. Am J Trop Med Hyg 56 (1997) 291-300
109. Ariaratnam C.A., Meyer W.P., Perera G., et al. A new monospecific ovine Fab fragment antivenom for treatment of envenoming by the Sri Lankan Russell's viper (Daboia russelii russelii): a preliminary dose-finding and pharmacokinetic study. Am J Trop Med Hyg 61 (1999) 259-265
110. Boyer L.V., Seifert S.A., Clark R.F., et al. Recurrent and persistent coagulopathy following pit viper envenomation. Arch Intern Med 159 (1999) 706-710
111. Rivière G., Choumet V., Audebert F., et al. Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy. J Pharmacol Exp Ther 281 (1997) 1-8
112. Kitchens C., and Eskin T. Fatality in a case of envenomation by Crotalus adamanteus initially successfully treated with polyvalent ovine antivenom followed by recurrence of defibrinogenation syndrome. J Med Toxicol 4 (2008) 180-183
113. Malasit P., Warrell D.A., Chanthavanich P., et al. Prediction, prevention, and mechanism of early (anaphylactic) antivenom reactions in victims of snake bites. BMJ (Clin Res Ed) 292 (1986) 17-20
114. Caron E.J., Manock S.R., Maudlin J., et al. Apparent marked reduction in early antivenom reactions compared to historical controls: was it prophylaxis or method of administration?. Toxicon 54 (2009) 779-783
115. Isbister G.K., Brown S.G., MacDonald E., et al. Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis. Med J Aust 188 (2008) 473-476
116. Rojas G., Jiménez J.M., and Gutiérrez J.M. Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production. Toxicon 32 (1994) 351-363
117. Klaewsongkram J. A role of snake antivenom skin test from the allergist's point of view. Acta Trop 109 (2009) 84-85
118. Cupo P., Azevedo-Marques M.M., de Menezes J.B., and Hering S.E. Immediate hypersensitivity reactions after intravenous use of antivenin sera: prognostic value of intradermal sensitivity tests. Rev Inst Med Trop Sao Paulo 33 (1991) 115-122
119. WHO. Rabies and envenomings: a neglected public health issue: report of a Consultative Meeting (2007), World Health Organization, Geneva
120. Harrison R.A., Hasson S.S., Harmsen M., et al. Neutralisation of venom-induced haemorrhage by IgG from camels and llamas immunised with viper venom and also by endogenous, non-IgG components in camelid sera. Toxicon 47 (2006) 364-368
121. Thallay B.S., and Carroll S.B. Rattle snake and scorpion antivenoms from the egg yolks of immunized hens. Biotechniques (NY) 8 (1990) 934-938
122. Theakston R.D., Warrell D.A., and Griffiths E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon 41 (2003) 541-557